Atazanavir Sulfate; Cobicistat Tablet — FDA Drug Shortage

No longer listed by FDA — Bristol Myers Squibb Co.

The FDA lists a drug shortage record for Atazanavir Sulfate; Cobicistat Tablet (tablet) from Bristol Myers Squibb Co. with status No longer listed by FDA. The shortage was first posted on Nov 3, 2025.

Shortage details

Status
No longer listed by FDA
Company
Bristol Myers Squibb Co.
Package NDC
0003-3641-11
Dosage Form
Tablet
Presentation
Evotaz, Tablet, 300 mg; 150 mg (NDC 0003-3641-11)
Initial Posting
Nov 3, 2025

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.